About ATNX

Founded in 2003, Athenex, Inc. is a global clinical stage biopharmaceutical company dedicated to becoming a leader in the discovery and development of next generation drugs for the treatment of cancer. Athenex is organized around three platforms including an Oncology Innovation Platform, a Commercial Platform and a Global Supply Chain Platform. Athenexs Oncology Innovation Platform generates clinical candidates through an extensive understanding of kinases, including novel binding sites, human absorption biology and through the application of Athenexs proprietary research and selection processes in the lab. The Companys current clinical pipeline is derived from two different platform technologies Athenex calls Orascovery and Src Kinase Inhibition. The Orascovery platform is based on the novel oral P-glycoprotein pump inhibitor molecule HM30181A, through which Athenex is able to facilitate oral absorption of traditional cytotoxics, which Athenex believes may offer improved patient tolerability and efficacy as compared to IV administration of the same cytotoxics. The Src Kinase Inhibition platform refers to novel small molecule compounds that have multiple mechanisms of action, including the inhibition of the activity of Src Kinase and the inhibition of tubulin polymerization during cell division. Athenex believes the combination of these mechanisms of action provides a broader range of anti-cancer activity as compared to either mechanism of action alone.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ATNX is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 212.2 M 2.1215E+08 234 234 0.07% 0.000679226 316 K 316062
UBIO Proshares UltraPro Nasdaq Biotechnology 28.4 M 2.839E+07 227 227 0.04% 0.000435929 40 K 40392
URTY ProShares UltraPro Russell2000 90.7 M 9.07335E+07 1,993 1993 0.01% 9.11771E-05 27 K 27126
UWM ProShares Ultra Russell2000 158.8 M 1.5876E+08 1,992 1992 0.02% 0.000153609 53 K 53064
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.4 B 1.39704E+09 2,261 2261 0.0% 2.8E-05 39 K 39235
VHT Vanguard Health Care ETF 8.7 B 8.7E+09 393 393 0.02% 0.00017 1.5 M 1513390
VTHR Vanguard Russell 3000 ETF 424.7 M 4.247E+08 2,959 2959 0.0% 2E-05 10 K 9581
VTI Vanguard Total Stock Market ETF 108.6 B 1.086E+11 3,570 3570 0.0% 2E-05 2.5 M 2517460
VTWG Vanguard Russell 2000 Growth ETF 282.8 M 2.828E+08 1,257 1257 0.06% 0.00064 180 K 179789
VTWO Vanguard Russell 2000 ETF 1.4 B 1.4E+09 2,010 2010 0.03% 0.00033 467 K 466587
VXF Vanguard Extended Market ETF 6.5 B 6.5E+09 3,237 3237 0.01% 0.00013 868 K 868308
LABU Direxion Daily S&P Biotech Bull 3X Shares 568.8 M 5.68759E+08 130 130 0.03% 0.000318313 636 K 636228
IBB iShares Nasdaq Biotechnology Index Fund 7.4 B 7.39335E+09 221 221 0.16% 0.0016 12.0 M 1.20392E+07
ITOT iShares Core S&P Total U.S. Stock Market ETF 21.0 B 2.1005E+10 3,548 3548 0.0% 0 619 K 618930
IWM iShares Russell 2000 ETF 41.2 B 4.1238E+10 1,983 1983 0.04% 0.0004 16.3 M 1.62752E+07
IWO iShares Russell 2000 Growth ETF 8.9 B 8.91978E+09 1,229 1229 0.07% 0.0007 6.7 M 6740400
IWV iShares Russell 3000 ETF 9.4 B 9.37678E+09 2,927 2927 0.0% 0 238 K 238100
XBI SPDR Series Trust SPDR S&P Biotech ETF 4.4 B 4.37881E+09 121 121 0.18% 0.00180327 7.9 M 7912832
FHLC Fidelity MSCI Health Care Index ETF 1.6 B 1.6E+09 369 369 0.02% 0.000201703 319 K 319027
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.1 B 2.1E+09 1,002 1002 0.01% 6.93719E-05 147 K 147461